Trials / Unknown
UnknownNCT02501993
Nasopharyngeal Carcinoma Screening in Zhongshan City
Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25,000 (estimated)
- Sponsor
- Zhongshan People's Hospital, Guangdong, China · Academic / Other
- Sex
- All
- Age
- 30 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to determine the early diagnosis rate and mortality rate of the Nasopharyngeal Carcinoma (NPC) in the study population. The secondary objective is to determine the incidence of NPC in the study population.
Detailed description
The research is to evaluate the effect of NPC screening, also as an extended study of Screening for Nasopharyngeal Carcinoma in High Risk Populations (NCT00941538). The program was conducted in Xiaolan and Minzhong towns of Zhongshan city in 2012. All participants will be tested for anti-EBV antibody by using serum samples. Participants are stratified into those having high, moderate and low antibody levels, those having moderate antibody levels are invited to retest annually in the following 3 years and those found to have high antibody levels on these occasions are referred to centers for diagnostic workup for NPC.
Conditions
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2019-12-01
- Completion
- 2023-12-01
- First posted
- 2015-07-17
- Last updated
- 2023-07-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02501993. Inclusion in this directory is not an endorsement.